Solesence, Inc.
Business Overview: Solésence, Inc. (NASDAQ: SLSN)
Executive Summary
Solésence, Inc. (formerly Nanophase Technologies Corporation) describes itself as a leading innovator in scientifically driven health, beauty, and wellness solutions, headquartered in Romeoville, Illinois, where it operates two Chicago-area, vertically integrated manufacturing facilities. The company builds on decades of materials-science work engineering nanoparticle active ingredients — principally surface-engineered zinc oxide and titanium dioxide used as sunscreen actives — and has used that base to move up the value chain into fully formulated, finished skincare, sun care, and color cosmetics products.
The company reports more than 950 developed SKUs and generated $62.1 million in revenue in 2025, up about 19% from $52.4 million in 2024, with its newer Consumer Products business ($54.9 million, roughly 88% of 2025 revenue) now dwarfing its legacy Personal Care Ingredients supply business. Solésence sells almost exclusively as a white-label and custom-formulation partner — it does not sell directly to consumers — making its brand largely invisible to shoppers even as its formulations end up on store shelves under other companies' names.
Solésence matters within the beauty-and-personal-care supply chain less for its size (it is a small-cap company with revenue concentrated among a handful of customers) and more for its specialized, proprietary mineral-active and dispersion technology — a niche where few competitors combine deep materials science with full-service consumer product formulation and manufacturing under one roof.
1. Core Business Model & How They Work
Solésence operates a vertically integrated model that spans from engineered raw materials through finished, packaged consumer product, selling almost entirely as a business-to-business formulation and manufacturing partner rather than a direct-to-consumer brand.
[ Engineered Nanomaterials (ZnO/TiO2) ] ➡️ [ Formulation (Active Stress Defense™ platforms) ] ➡️ [ Manufacturing & Packaging ] ➡️ [ Brand Partner Sale (White-Label / Custom) ] ➡️ [ Brand Partner's Retail Shelf ]Key Operational Drivers
- Shift from ingredient supplier to finished-goods partner: The company's historical business was selling engineered active pharmaceutical ingredients (APIs) — principally zinc oxide and titanium dioxide made to cGMP standards — to other manufacturers. Its strategic priority has shifted to Consumer Products: market-ready, white-label, or fully custom-developed skin care, sun care, and color cosmetics sold to brand partners who market them under their own names.
- Proprietary dispersion and UV-formulation technology: Solésence's Active Stress Defense™ platforms and surface-engineering know-how for mineral UV filters are the technical core the company leans on to differentiate from both larger chemical companies and smaller contract formulators.
- Vertically integrated, two-facility manufacturing footprint: Owning materials engineering, formulation, and manufacturing/packaging under one roof (rather than outsourcing any step) lets Solésence offer brand partners a single accountable supply chain and faster custom-development cycles.
- Concentrated but strategic customer base: Revenue is meaningfully concentrated — the three largest customers (two consumer-products brand partners and BASF, its largest Personal Care Ingredients customer) made up roughly 29%, 16%, and 10% of 2025 revenue, respectively. Long-term agreements with BASF provide some durability, though they remain terminable under certain conditions.
- Legacy Advanced Materials: A smaller, non-prioritized line of legacy nanoparticle materials for life science, food packaging, and coatings applications rounds out the portfolio but is not a growth focus.
2. Business Segments
Solésence reports as a single operating segment. Internally, however, the business is best understood through three product lines rather than formal financial segments, so no segment-level revenue-share chart is presented here; the split below reflects product-line, not segment, reporting.
- Consumer Products (~88% of 2025 revenue) — finished, formulated skin care, sun care, and color cosmetics sold white-label or custom-developed to brand partners.
- Personal Care Ingredients (~remainder of revenue) — surface-engineered zinc oxide and titanium dioxide APIs sold mainly for use in sunscreens, led by its BASF relationship.
- Advanced Materials (small, non-prioritized) — legacy nanoparticle materials for life science, food packaging, and coatings uses.
3. Product Portfolio
| Offering | Category | Purpose | Why It Matters |
|---|---|---|---|
| Active Stress Defense™ formulations | Consumer Products (skin care / sun care) | Finished, white-label or custom-developed skincare and sun care products sold to brand partners | The company's primary growth engine; drove 2025 Consumer Products revenue of $54.9 million, 88% of total revenue. |
| Color Cosmetics | Consumer Products | Formulated cosmetics sold under brand-partner labels | Diversifies the Consumer Products line beyond sun/skin care and leverages the same formulation and manufacturing base. |
| Surface-engineered zinc oxide / titanium dioxide APIs | Personal Care Ingredients | cGMP-grade mineral UV-filter active ingredients sold to other formulators and manufacturers | The company's original technology base; BASF is the largest customer in this line, providing a long-term but not guaranteed revenue anchor. |
| Legacy nanoparticle materials | Advanced Materials | Materials for life science, food packaging, and coatings applications | Smaller, de-prioritized legacy line; not a strategic growth focus but still contributes some revenue. |
4. Competitive Landscape
Solésence competes across two distinct layers of the beauty and personal-care supply chain: as a finished-product formulator/manufacturer, and as a specialty mineral-ingredient supplier.
Consumer Products (Private-Label Formulation & Manufacturing)
- Key Competitors: Large private-label and contract cosmetics manufacturers, and brands that manufacture in-house rather than outsourcing.
- Dynamics: Per its own 10-K, Solésence "faces competition from a wide variety of offerings," including many brands with in-house manufacturing capability. The company's differentiation rests on its proprietary dispersion technology, UV-formulation expertise, and ability to move from concept to custom-formulated product faster than less specialized contract manufacturers — important given the fast-moving nature of beauty-industry product cycles.
Personal Care Ingredients
- Key Competitors: Larger, more diversified advanced-materials and specialty-chemical companies, as well as traditional lower-priced mineral UV-filter suppliers.
- Dynamics: Solésence is a smaller, more specialized player against much larger diversified chemical companies; its edge is technical (surface-engineered particle quality for sunscreen performance) rather than scale or price, which is also why its largest ingredients customer, BASF, works with it on long-term agreements rather than commodity-style purchasing.
5. Strategic Strengths & Risks
Strategic Strengths (The Moat)
- Proprietary mineral-active and dispersion technology: Decades of materials-science work in surface-engineered zinc oxide and titanium dioxide give Solésence technical capability that is not trivially replicated by a generalist contract manufacturer.
- Vertical integration: Owning the full chain from engineered material through finished, packaged consumer product under one roof is uncommon among private-label beauty suppliers and supports faster custom-development turnaround for brand partners.
- Durable anchor relationship with BASF: A long-term agreement with a top-tier chemical company for Personal Care Ingredients lends some revenue durability to the legacy ingredients business even as Consumer Products becomes the larger growth driver.
Strategic Risks & Vulnerabilities
- Customer concentration: The three largest customers accounted for roughly 55% of 2025 revenue combined (approximately 29%, 16%, and 10%), and the company itself expects smaller customers to represent a larger share over time — meaning near-term results remain sensitive to order timing from just a few brand partners, as seen in 2026 quarterly revenue swings tied to shipment and launch timing.
- No consumer-facing brand power: Because Solésence sells almost entirely as a white-label/custom partner, it has limited ability to build direct brand loyalty with end consumers — its commercial fate is tied to its brand partners' own marketing success.
- Related-party financing reliance: The company has relied on related-party loans from entities (Beachcorp and Strandler) affiliated with its controlling shareholder to fund operations amid negative operating cash flow (an $8.6 million operating cash outflow in 2025), a structure that concentrates financial leverage with an insider rather than diversified outside lenders.
- Terminable key agreements: Long-term agreements such as the BASF relationship remain terminable under certain circumstances, so the ingredients business's durability is not absolute.
6. Financial Overview
| Metric / Dimension | Solésence (SLSN) Profile | Strategic Context |
|---|---|---|
| Annual Revenue | $62.1 million in 2025, up ~19% from $52.4 million in 2024 | Growth driven almost entirely by the Consumer Products shift; quarterly results in 2026 have shown volatility tied to shipment and launch timing. |
| Revenue Mix | ~88% Consumer Products, remainder Personal Care Ingredients / Advanced Materials | Confirms the company's center of gravity has moved from ingredient supply to finished consumer goods. |
| Customer Concentration | Top 3 customers ≈ 55% of 2025 revenue | A meaningful single-customer risk factor for a company of this size; order-pipeline reports (e.g., a cited ~$47 million order backlog in 2026) partly offset this concern. |
| Operating Cash Flow | Negative (~$8.6 million outflow in 2025) | Funded in part by related-party loans from controlling-shareholder affiliates — a financing structure worth monitoring rather than a going-concern-level red flag. |
| Market Capitalization | Roughly $60 million range (small-cap, NASDAQ-listed) | Reflects both the company's growth narrative and the market's discount for customer concentration and recent earnings volatility. |
7. Summary Conclusion
Solésence's business model — engineering proprietary mineral actives and dispersion technology, then wrapping that capability in vertically integrated, white-label consumer-product manufacturing — gives it a genuine, if narrow, technical moat within a corner of the beauty and personal-care supply chain that larger, more diversified chemical and contract-manufacturing competitors don't fully replicate.
The company's path forward depends on converting that technical edge into a broader, less concentrated customer base: its biggest near-term risk is not competitive displacement but revenue lumpiness tied to a handful of large brand-partner relationships and shipment timing, layered on top of a financing structure that currently leans on its controlling shareholder's affiliates rather than diversified capital sources.